EXEL · Company research

Exelixis Inc (EXEL): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 202658.44$15,380,436,63015098988630.0071.1829268292682927—2.721700143472023424.46426160746950018.341877438628196051.1105312951732168

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.